IPO - Klotho Neurosciences, Inc.

Form Type: CORRESP

Filing Date: 2025-02-07

Corporate Action: Ipo

Type: New

Accession Number: 000121390025011169

Filing Summary: Klotho Neurosciences, Inc. filed a request to accelerate the effective date of its Registration Statement on Form S-1, which was previously filed on January 30, 2025. The company seeks to have the Registration Statement declared effective at 4:30 p.m. ET on February 10, 2025, or as soon thereafter as practicable, unless a different time is requested by the company or its outside counsel, Paul Goodman. Any inquiries regarding this filing should be directed to Paul Goodman, Esq.

Document Link: View Document

Form Type: S-1

Filing Date: 2025-01-30

Corporate Action: Ipo

Type: New

Accession Number: 000121390025008318

Filing Summary: On January 30, 2025, Klotho Neurosciences, Inc. filed a registration statement for an initial public offering (IPO) of shares. This S-1 filing includes prospective sales of up to 43,680,219 shares of common stock. Of this amount, 37,876,100 shares are intended for issuance to investors upon the conversion of promissory notes and exercise of warrants, while 5,804,119 shares are held by selling shareholders. The company has stated that it will not receive proceeds from the sale of shares by the selling stockholders, although it may obtain funds from the exercise of any warrants that are not exercised on a cashless basis. The offering price for the shares has been estimated based on market prices from January 27, 2025. The document emphasizes that the information is subject to change and the SEC has not approved the offerings. Investing in the shares presents significant risks and the company warns potential investors regarding the high degree of risk involved. The company is listed on the NASDAQ under the symbol 'KLTO.'

Document Link: View Document